Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 11.7054.18-2.417.3270.71

What is the latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 11.70 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar202611.70
Mar202554.18
Mar2024-2.41
Mar20237.32
Mar202270.71

How is EBIT Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2026 11.7
-78.41
Mar2025 54.18
Positive
Mar2024 -2.41
Negative
Mar2023 7.32
-89.65
Mar2022 70.71 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹39,958.9 Cr 1.1% 3.3% -26.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,792.0 Cr 1.4% 1.2% 13.8% Stock Analytics
DIVIS LABORATORIES ₹178,152.0 Cr -0.5% -0.6% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,915.0 Cr 2.1% 1.5% 42.2% Stock Analytics
CIPLA ₹116,354.0 Cr 6.4% 1.6% -3.1% Stock Analytics
DR REDDYS LABORATORIES ₹112,681.0 Cr 6.2% 1.6% 0.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

1.1%

3.3%

-26.3%

SENSEX

-0.4%

0.8%

-5.3%


You may also like the below Video Courses